ALPS Medical Breakthroughs ETF SBIO
52.83 USD -2.98 (-5.34%)
At closeNov 6, 2026, 4:00 AM EST
52.83 0.00 0.00%
Pre-market · Nov 6, 4:00 AM ET
52.83 Day range 55.09
43.10 52-week range 70.85
- YTD
- +3.14%
- 1 year
- +20.78%
- Market cap
- 176.99M
- YTD return
- +3.14%
- 1-year return
- +20.78%
- Volume
- 20.39K
- Avg volume
- 38.46K
- Open
- 55.96
- Previous close
- 55.81
- Day's range
- 52.83 – 55.09
- 52-week range
- 43.10 – 70.85
6M -3.55 (-6.30%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 38.30
- 200-day average
- 35.94
About ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SBIO — it syncs with the Stock Master app.